Operating Lease, Right-of-Use Asset of ACCENDRA HEALTH INC/VA/ from 31 Dec 2018 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
ACCENDRA HEALTH INC/VA/ quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2018 to 30 Sep 2025.
  • ACCENDRA HEALTH INC/VA/ Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $119,093,000, a 67% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

ACCENDRA HEALTH INC/VA/ Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $119,093,000 -$238,171,000 -67% 30 Sep 2025 10-Q 31 Oct 2025 2025 Q3
Q2 2025 $120,188,000 -$248,283,000 -67% 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 $383,111,000 +$33,127,000 +9.5% 31 Mar 2025 10-Q 08 May 2025 2025 Q1
Q4 2024 $126,928,000 -$169,605,000 -57% 31 Dec 2024 10-Q 31 Oct 2025 2025 Q3
Q3 2024 $357,264,000 +$57,000,000 +19% 30 Sep 2024 10-Q 04 Nov 2024 2024 Q3
Q2 2024 $368,471,000 +$75,662,000 +26% 30 Jun 2024 10-Q 02 Aug 2024 2024 Q2
Q1 2024 $349,984,000 +$73,422,000 +27% 31 Mar 2024 10-Q 03 May 2024 2024 Q1
Q4 2023 $296,533,000 +$15,868,000 +5.7% 31 Dec 2023 10-K 28 Feb 2025 2024 FY
Q3 2023 $300,264,000 +$24,431,000 +8.9% 30 Sep 2023 10-Q 03 Nov 2023 2023 Q3
Q2 2023 $292,809,000 +$14,518,000 +5.2% 30 Jun 2023 10-Q 04 Aug 2023 2023 Q2
Q1 2023 $276,562,000 -$1,643,000 -0.59% 31 Mar 2023 10-Q 05 May 2023 2023 Q1
Q4 2022 $280,665,000 +$86,659,000 +45% 31 Dec 2022 10-K 20 Feb 2024 2023 FY
Q3 2022 $275,833,000 +$91,279,000 +49% 30 Sep 2022 10-Q 02 Nov 2022 2022 Q3
Q2 2022 $278,291,000 +$103,339,000 +59% 30 Jun 2022 10-Q 03 Aug 2022 2022 Q2
Q1 2022 $278,205,000 +$123,053,000 +79% 31 Mar 2022 10-Q 04 May 2022 2022 Q1
Q4 2021 $194,006,000 +$49,251,000 +34% 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q3 2021 $184,554,000 +$41,192,000 +29% 30 Sep 2021 10-Q 03 Nov 2021 2021 Q3
Q2 2021 $174,952,000 +$32,752,000 +23% 30 Jun 2021 10-Q 03 Aug 2021 2021 Q2
Q1 2021 $155,152,000 +$21,414,000 +16% 31 Mar 2021 10-Q 05 May 2021 2021 Q1
Q4 2020 $144,755,000 +$2,536,000 +1.8% 31 Dec 2020 10-K 23 Feb 2022 2021 FY
Q3 2020 $143,362,000 -$91,491,000 -39% 30 Sep 2020 10-Q 03 Nov 2020 2020 Q3
Q2 2020 $142,200,000 -$63,999,000 -31% 30 Jun 2020 10-Q 05 Aug 2020 2020 Q2
Q1 2020 $133,738,000 -$63,462,000 -32% 31 Mar 2020 10-Q 06 May 2020 2020 Q1
Q4 2019 $142,219,000 +$142,219,000 31 Dec 2019 10-K 24 Feb 2021 2020 FY
Q3 2019 $234,853,000 30 Sep 2019 10-Q 06 Nov 2019 2019 Q3
Q2 2019 $206,199,000 30 Jun 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 $197,200,000 31 Mar 2019 10-Q 07 May 2019 2019 Q1
Q4 2018 $0 31 Dec 2018 10-Q 06 Nov 2019 2019 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.